Antineuropathic and Antinociceptive Drugs Combination in Patients with Chronic Low Back Pain : A Systematic Review

Abstract EN

Purpose.

Chronic low back pain (LBP) is often characterized by both nociceptive and neuropathic components.

While various monotherapies have been reported of only limited efficacy, combining drugs with different mechanisms of action and targets appears a rational approach.

Aim of this systematic review is to assess the efficacy and safety of different combined pharmacological treatments, compared to monotherapy or placebo, for the pharmacological treatment of chronic LBP.

Methods.

Published papers, written or abstracted in English from 1990 through 2011, comparing combined pharmacological treatments of chronic LBP to monotherapy or placebo were reviewed.

Results.

Six articles met the inclusion criteria.

Pregabalin combined with celecoxib or opioids was shown to be more effective than either monotherapy.

Oxycodone-paracetamol versus previous treatments and tramadol-paracetamol versus placebo were also reported as effective, while morphine-nortriptyline did not show any benefit over any single agent.

Conclusions.

In spite of theoretical advantages of combined pharmacological treatments of chronic LBP, clinical studies are remarkably few.

Available data show that combined therapy, including antinociceptive and antineuropathic agents is more effective than monotherapy, with similar side effects.